Skip to main content
. 2013 May 3;13:222. doi: 10.1186/1471-2407-13-222

Figure 4.

Figure 4

Survivals in ENKL with low-risk KPI stratified by the prognostic index. Overall survival (A) and progression-free survival (B) of patients with low-risk KPI score (KPI score = 0–1, n=84) as determined by the absolute monocyte and lymphocyte prognostic index. KPI, Korean Prognostic Index. Group 1 (low risk), AMC <0.50×109/L and ALC>1.10×109/L; Group 2 (intermediate risk), AMC ≥ 0.50×109/L or ALC ≤ 1.10×109/L; Group 3 (high risk), AMC ≥ 0.50×109/L and ALC ≤ 1.10×109/L.